Trial Information

Summary: Development of a Blood Test of Anti-IMP3 Autoantibody for the Detection of Renal Cell Carcinoma with Metastasis and Metastatic Potential

You have been asked to participate in this research study because you have been diagnosed with or are suspected to have renal cell carcinoma (RCC) (kidney cancer). The purpose of this study is to develop a blood test to detect whether RCC has metastasized (spread into other organ(s)). Your participation on this study is expected to last as long as it takes to draw additional blood at the time of your routine blood test(s) before surgery. 

Patient Inclusion/Exclusion Criteria:

- See http://clinicaltrials.coh.org for additional information.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: October 6, 2008 at 3:02:28 PM